Select Publications
Journal articles
2014, 'Human antigen-specific CD4+CD25+CD134+CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses', European Journal of Immunology, 44, pp. 1644 - 1661, http://dx.doi.org/10.1002/eji.201344102
,2014, 'Identifying chagas disease in Australia: An emerging challenge for general practitioners', Australian Family Physician, 43, pp. 440 - 442
,2014, 'Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy', Journal of Infection, 68, pp. 344 - 354, http://dx.doi.org/10.1016/j.jinf.2013.11.016
,2014, 'Ratios of effector to central memory antigen-specific CD4 + T cells vary with antigen exposure in HIV+ patients', Immunology and Cell Biology, 92, pp. 384 - 388, http://dx.doi.org/10.1038/icb.2013.101
,2014, 'Determinants of IL-6 levels during HIV infection.', J Int AIDS Soc, 17, pp. 19482, http://dx.doi.org/10.7448/IAS.17.4.19482
,2013, 'Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0077479
,2013, 'Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc switch collaborative study', Journal of Clinical Microbiology, 51, pp. 2063 - 2071, http://dx.doi.org/10.1128/JCM.00510-13
,2013, 'Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study', PLoS ONE, 8, pp. e56249, http://dx.doi.org/10.1371/journal.pone.0056249
,2013, 'Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 62, pp. 525 - 533, http://dx.doi.org/10.1097/QAI.0b013e3182832578
,2013, 'The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies', PLoS ONE, 8, pp. e57121, http://dx.doi.org/10.1371/journal.pone.0057121
,2012, 'A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays', Tuberculosis, 92, pp. 321 - 327, http://dx.doi.org/10.1016/j.tube.2012.03.008
,2012, 'A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 60, pp. 143 - 149, http://dx.doi.org/10.1097/QAI.0b013e318252f97e
,2012, 'Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men.', Sexual Health, 10, pp. 9 - 17, http://dx.doi.org/10.1071/SH11135
,2012, 'Clinical studies with chemokine receptor-5 (CCR5)-inhibitors', Current opinion in HIV & AIDS, 7, pp. 456 - 462, http://dx.doi.org/10.1097/COH.0b013e328356e933
,2012, 'Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study', CLINICAL TRIALS, pp. 1 - 32, http://dx.doi.org/10.1177/1740774512440342
,2011, 'Enfuvirtide injection site reactions: A clinical and histopathological appraisal', Australasian Journal of Dermatology, 52, pp. 19 - 26, http://dx.doi.org/10.1111/j.1440-0960.2010.00717.x
,2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, 8, pp. 255 - 256, http://search.informit.com.au/documentSummary;dn=026919938891985;res=IELHEA
,2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, 8, pp. 257 - 258, http://search.informit.com.au/documentSummary;dn=026957204834502;res=IELHEA
,2011, 'Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)', HIV Medicine, 12, pp. 219 - 227, http://dx.doi.org/10.1111/j.1468-1293.2010.00875.x
,2011, 'Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site netwok approach: The INSIGHT FLU 002 and FLU 003 studies', Vaccine, 29, pp. B56 - B62
,2010, 'A novel Chemokine-Receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection', AIDS Research and Human Retroviruses, 26, pp. 653 - 661, http://dx.doi.org/10.1089/aid.2009.0278
,2010, 'Antiretroviral agents: Focus on maraviroc for the treatment of HIV-1-infected adults', Clinical Medicine Insights: Therapeutics, 2, pp. 697 - 713, http://www.la-press.com/
,2010, 'Antiretroviral agents: Focus on Maraviroc for the Treatment of HIV-1-Infected Adults', Clinical Medicine Insights: Therapeutics, 2, http://dx.doi.org/10.4137/cmt.s5420
,2010, 'Markers of inflammation, coagulation and renal function are elevated in adults with HIV infection', Journal of Infectious Diseases, 201, pp. 1788 - 1795
,2010, 'Role of interleukin-2 inpatients with HIV infection', Drugs, 70, pp. 1115 - 1130
,2009, 'A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients', Antiviral Therapy, 14, pp. 111 - 115
,2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)', Journal of Immunology, 183, pp. 2827 - 2836, http://dx.doi.org/10.4049/jimmunol.0803548
,2009, 'Immunotherapies in HIV-1 infection', Current opinion in HIV & AIDS, 4, pp. 188 - 193
,2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease', European Journal of Immunology, 39, pp. 391 - 403, http://dx.doi.org/10.1002/eji.200838630
,2008, 'Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy', Journal of the International AIDS Society, 11, http://dx.doi.org/10.1186/1758-2652-11-s1-p297
,2008, 'Experimental and clinical pharmacology - HIV fusion inhibitors: a review', Australian Prescriber, 31, pp. 66 - 69
,2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, 14, pp. 52 - 59
,2006, 'Evaluation of Subcutaneous Proleukin (Interleukin-2) in a Randomized International Trial (ESPRIT): Geographical and Gender Differences in the Baseline Characteristics of Participants', HIV Research & Clinical Practice, 7, pp. 70 - 85, http://dx.doi.org/10.1310/hct.2006.7.2.005
,2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85
,2006, 'Post-kala-azar dermal leishmaniasis due to Leishmania infantum in a human immunodeficiency virus type 1-infected patient', Journal of Clinical Microbiology, 44, pp. 1178 - 1180
,2006, 'Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials', HIV Clinical Trials, 7, pp. 125 - 141
,2005, 'Iatrogenic Cushing`s syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: Six cases', Journal of Clinical Endocrinology and Metabolism, 90, pp. 4394 - 4398
,2004, 'Antiretroviral therapy-induced immune restoration in HIV infection: A double-edged sword?', Expert Review of Anti-Infective Therapy, 2, pp. 335 - 339, http://dx.doi.org/10.1586/14787210.2.3.335
,2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98
,2003, 'Cytokine therapies in HIV-1 infection: Present and future', Expert Review of Anti-Infective Therapy, 1, pp. 83 - 96, http://dx.doi.org/10.1586/14787210.1.1.83
,2003, 'Cytokine therapies in HIV-1 infection: present and future', Expert Review of Anti-Infective Therapy, 1, pp. 89 - 102
,2003, 'Cytomegalovirus polymerase chain reaction tests can replace endoscopy and biopsy for the initial diagnosis of cytomegalovrius gastrointestinal disease in patients following heart transplantation', CSANZ
,2002, 'Cyclical hepatitis and early liver cirrhosis after hepatitis C seroconversion during pulsed antiretroviral therapy for primary HIV-1', AIDS, 16, pp. 2364 - 2365
,2001, 'Immunomodulators as adjunctive therapy for HIV-1 infection', Journal of Clinical Virology, 22, pp. 289 - 295, http://dx.doi.org/10.1016/S1386-6532(01)00201-3
,2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine', AIDS Research and Human Retroviruses, 17, pp. 1293 - 1296, http://dx.doi.org/10.1089/088922201750461366
,2000, 'Current review of the metabolic and endocrine disturbances in human immunodeficiency virus infection', Current Opinion in Endocrinology and Diabetes, 7, pp. 96 - 101, http://dx.doi.org/10.1097/00060793-200004000-00009
,2000, 'Current review of the metabolic and endocrine disturbances in human immunodeficiency virus infection', Current Opinion in Endocrinology & Diabetes, 7, pp. 96 - 101, http://dx.doi.org/10.1097/00075197-200004000-00009
,1993, 'The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.', J Exp Med, 178, pp. 427 - 438, http://dx.doi.org/10.1084/jem.178.2.427
,Conference Papers
2019, 'P499 Human papillomavirus detection in residual samples from STI tests in men who have sex with men', in Poster Presentations, BMJ Publishing Group Ltd, pp. A230.2 - A230, presented at Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada, http://dx.doi.org/10.1136/sextrans-2019-sti.580
,2013, 'Proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study (MARCH) - results of a three-phase quality assurance (QA) programme', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Toronto, pp. A144 - A144, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CANADA, Toronto, 04 June 2013 - 08 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335229500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,